AbbVie is trading at $251.79 (+3.15%) in mid-morning trading, driven by broad strength across the healthcare sector.
- The Health Care Select Sector SPDR Fund (XLV) is up 2.12% as sentiment improves across the group, tracking a wider risk-on tone in the industry.
- The rally is supported by positive industry headlines and gains in large-cap health insurers, despite no company-specific catalyst for AbbVie.
- The move reflects a general rotation into healthcare names as the broader market shows increased appetite for the sector.